2/25, 1:15 PM (Source: TeleTrader)
more TeleTrader news

Pfizer to test if 3rd vaccine dose neutralizes strains

Pfizer Inc. and BioNTech SE announced on Thursday they would begin trials to determine if the third dose of their vaccine against COVID-19 neutralized new variants of the disease.

The companies stated they would test people from two age groups that had already received two doses of their jab. The first group would feature persons aged 18–55, and the second one those aged 65–85.

The firms added they had found no evidence that new strains of the virus led to a "loss of the protection provided by our vaccine," but added they would continue to explore new versions of the jab if the original one proved to be ineffective against other variants of the disease.

Breaking the News / JR